Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer
Clinical trial NCT04191382 · TERMINATED
Trial details
- NCT number
- NCT04191382
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2021-04-30
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.